CollPlant Biotechnologies Ltd. (CLGN)
4.19
+0.08
(+1.95%)
USD |
NASDAQ |
Nov 04, 14:50
CollPlant Biotechnologies Market Cap : 6.052M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 5.936M |
| November 02, 2026 | 5.893M |
| October 30, 2026 | 5.973M |
| October 29, 2026 | 6.355M |
| October 28, 2026 | 5.705M |
| October 27, 2026 | 5.633M |
| October 26, 2026 | 5.416M |
| October 23, 2026 | 5.301M |
| October 22, 2026 | 5.229M |
| October 21, 2026 | 5.424M |
| October 20, 2026 | 5.604M |
| October 19, 2026 | 5.142M |
| October 16, 2026 | 5.236M |
| October 15, 2026 | 5.315M |
| October 14, 2026 | 5.965M |
| October 13, 2026 | 5.648M |
| October 12, 2026 | 5.806M |
| October 09, 2026 | 5.070M |
| October 08, 2026 | 5.734M |
| October 07, 2026 | 4.998M |
| October 06, 2026 | 4.896M |
| October 05, 2026 | 4.925M |
| October 02, 2026 | 4.998M |
| October 01, 2026 | 5.156M |
| September 30, 2026 | 5.460M |
| Date | Value |
|---|---|
| September 29, 2026 | 5.474M |
| September 28, 2026 | 5.590M |
| September 25, 2026 | 6.139M |
| September 24, 2026 | 59.42M |
| September 23, 2026 | 58.27M |
| September 22, 2026 | 55.53M |
| September 21, 2026 | 62.02M |
| September 18, 2026 | 65.77M |
| September 17, 2026 | 60.00M |
| September 16, 2026 | 50.19M |
| September 15, 2026 | 49.04M |
| September 14, 2026 | 50.34M |
| September 11, 2026 | 50.48M |
| September 10, 2026 | 51.06M |
| September 09, 2026 | 49.18M |
| September 08, 2026 | 51.64M |
| September 04, 2026 | 51.20M |
| September 03, 2026 | 49.21M |
| September 02, 2026 | 49.52M |
| September 01, 2026 | 53.74M |
| August 31, 2026 | 55.95M |
| August 28, 2026 | 51.64M |
| August 27, 2026 | 41.78M |
| August 26, 2026 | 44.35M |
| August 25, 2026 | 41.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 274.35M |
| Perspective Therapeutics, Inc. | 101.51M |
| MiMedx Group, Inc. | 462.58M |
| Regentis Biomaterials Ltd. | 9.623M |
| Xylo Technologies Ltd. | 4.089M |
Market Cap Related Metrics
| PS Ratio | 134.12 |
| PEG Ratio | -0.0118 |
| Price to Book Value | 2.055 |
| Price | 4.19 |
| Earnings Yield | -62.99% |
| PEGY Ratio | -0.0118 |